“Complete responses with NK cell therapy. The power of the Bioshield platform.
A tumor agnostic chemo free paradigm change by treating the immune system. The lymphoma trial is open. Contact the Chan Soon-Shiong Institute for Medicine (CSSIFM) to enroll.
The power of NK cells. After a single cycle of NK cells targeting the tumor, the patient with a rare lymphoma (WM) -90 percent of bone marrow infiltrated ( left PET scan) achieved a COMPLETE RESPONSE (right scan). Had failed all other therapy. The power of the BIOSHIELD platform.”